Breaking barriers: Understanding and managing blood-spinal cord barrier dysfunction in spinal cord injury: A systematic review
Journal of Clinical Orthopaedics and Trauma · 2026-05 · 76 · 103401
DOI: 10.1016/j.jcot.2026.103401 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Orthopaedics and Trauma, 2026-05. Verfasst von Eslam Abourisha und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Spinal cord injury (SCI) has life-changing consequences, not just from the initial trauma, but also from a series of damaging processes that unfold afterwards, such as oxidative stress, inflammation, and nerve cell loss. At the heart of these events is the breakdown of the blood-spinal cord barrier (BSCB). When BSCB fails, harmful substances start flooding in, leading to progressive tissue damage.
Methods
In this review, we explore findings from 38 studies - including animal models and patient research - to shed light on how and why the BSCB fails after SCI, as well as what can be done to diagnose and treat this problem. The systematic review was registered with PROSPERO (ID No- 1173511).
Results
New diagnostic tools, like specialized MRI scans and blood or spinal fluid biomarkers, are helping doctors track changes in the BSCB. The causes of barrier breakdown are complex, involving oxidative stress, iron buildup, enzyme activity, genetic regulation, and immune responses, all of which make the injury worse over time. Promising treatments include a wide range from medicines and biological therapies to physical approaches like targeted exercise or nerve stimulation-all showing benefits in laboratory studies, though we still need more real-world evidence.
Conclusions
Protecting BSCB represents a promising but underutilized treatment strategy for spinal cord injury. BSCB dysfunction is diffuse, persistent, and biologically reversible across acute-subacute stages, providing a rationale for stage-specific therapeutic targeting. Based on the latest research, we offer a practical pathway for doctors to detect and manage BSCB damage - matching the type of treatment to the stages of SCI recovery. Greater consistency in research, early clinical trials, and better use of new biomarkers will help move these therapies from the lab to everyday patient care. Ultimately, preserving the BSCB after injury is not just about protecting tissue - it's about giving people a better chance at recovery and a return to their lives.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
- Wye Valley NHS Trust, Hereford, United Kingdom.
- Norfolk and Norwich University Hospital, Norwich, United Kingdom.
- Sreeraam Research Centre, Sree Raam Nursing Home and Hospital, Tamil Nadu, India.
Zitieren
APA
Abourisha, E., Talavia, T. J., Jha, G., Bharadwaj, S., Curran, A., & Srinivasan, S. H. (2026). Breaking barriers: Understanding and managing blood-spinal cord barrier dysfunction in spinal cord injury: A systematic review. Journal of Clinical Orthopaedics and Trauma, 76, 103401. https://doi.org/10.1016/j.jcot.2026.103401
Vancouver
Abourisha E, Talavia TJ, Jha G, Bharadwaj S, Curran A, Srinivasan SH. Breaking barriers: Understanding and managing blood-spinal cord barrier dysfunction in spinal cord injury: A systematic review. Journal of Clinical Orthopaedics and Trauma. 2026;76:103401. doi:10.1016/j.jcot.2026.103401
BibTeX
@article{Abourisha2026,
author = {Abourisha, Eslam and Talavia, Tanmay Jitendra and Jha, Gaurav and Bharadwaj, Sanjeevi and Curran, Alexander and Srinivasan, Sriram Harish},
title = {Breaking barriers: Understanding and managing blood-spinal cord barrier dysfunction in spinal cord injury: A systematic review},
journal = {Journal of Clinical Orthopaedics and Trauma},
year = {2026},
volume = {76},
pages = {103401},
doi = {10.1016/j.jcot.2026.103401}
}
EUVIMED